Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises...

Published on 25 Oct 2024 on Benzinga · via Yahoo Finance

On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 billion...

Read the rest of the article

Start tracking your investments with Statfolio

In his iconic song The Gambler, Kenny Rogers famously sang, “Every hand’s a winner, and every han...

TipRanks · via Yahoo Finance 29 Oct 2024

Regeneron last year won approval for a higher-dose version of its star eye disease drug Eylea -- ...

The Motley Fool · via AOL 28 Oct 2024

Welcome to the Q3 2024 conference call for investors and analysts. As usual, you can find the sli...

The Motley Fool · via AOL 25 Oct 2024

The results show that Ebglyss improved skin (including hand and face) and itch among patients wit...

Benzinga · via Yahoo Finance 25 Oct 2024

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in ...

Reuters · via Yahoo Finance 25 Oct 2024

On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 bill...

Benzinga · via AOL 25 Oct 2024

According to FactSet, the company posted profit of $1.54 per share on $14.51 billion in sales. Sa...

Investor's Business Daily 25 Oct 2024

The company’s performance beat Wall Street expectations, pushing its share price higher in Friday...

BioPharma Dive · via Yahoo Finance 25 Oct 2024

On Friday, Sanofi SA (NASDAQ:SNY) reported a third-quarter business operating income of 4.61 bill...

Benzinga · via Yahoo Finance 25 Oct 2024

French drug maker Sanofi on Friday posted stronger earnings growth than analysts had expected in ...

Reuters · via Yahoo Finance 25 Oct 2024